ZA200708071B - Crystalline form of a quinolinone-carboxamide compound - Google Patents

Crystalline form of a quinolinone-carboxamide compound

Info

Publication number
ZA200708071B
ZA200708071B ZA200708071A ZA200708071A ZA200708071B ZA 200708071 B ZA200708071 B ZA 200708071B ZA 200708071 A ZA200708071 A ZA 200708071A ZA 200708071 A ZA200708071 A ZA 200708071A ZA 200708071 B ZA200708071 B ZA 200708071B
Authority
ZA
South Africa
Prior art keywords
quinolinone
crystalline form
carboxamide compound
carboxamide
compound
Prior art date
Application number
ZA200708071A
Other languages
English (en)
Inventor
Paul R Fatheree
Goldblum Adam
Genov Daniel
Turner S Derek
Chao Robert
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of ZA200708071B publication Critical patent/ZA200708071B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200708071A 2005-04-06 2007-09-19 Crystalline form of a quinolinone-carboxamide compound ZA200708071B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66878005P 2005-04-06 2005-04-06

Publications (1)

Publication Number Publication Date
ZA200708071B true ZA200708071B (en) 2008-10-29

Family

ID=37074104

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200708071A ZA200708071B (en) 2005-04-06 2007-09-19 Crystalline form of a quinolinone-carboxamide compound

Country Status (29)

Country Link
US (4) US7728004B2 (OSRAM)
EP (1) EP1874766B1 (OSRAM)
JP (2) JP5230407B2 (OSRAM)
KR (1) KR101322873B1 (OSRAM)
CN (1) CN101151264B (OSRAM)
AR (2) AR053208A1 (OSRAM)
AT (1) ATE479682T1 (OSRAM)
AU (1) AU2006232129B2 (OSRAM)
BR (1) BRPI0610657A2 (OSRAM)
CA (1) CA2603654C (OSRAM)
CY (1) CY1111275T1 (OSRAM)
DE (1) DE602006016586D1 (OSRAM)
DK (1) DK1874766T3 (OSRAM)
EA (1) EA012115B1 (OSRAM)
ES (1) ES2350495T3 (OSRAM)
HR (1) HRP20100629T1 (OSRAM)
IL (1) IL186023A (OSRAM)
MA (1) MA29403B1 (OSRAM)
MX (1) MX2007012438A (OSRAM)
MY (1) MY151075A (OSRAM)
NO (1) NO339699B1 (OSRAM)
NZ (1) NZ561900A (OSRAM)
PE (1) PE20061310A1 (OSRAM)
PL (1) PL1874766T3 (OSRAM)
PT (1) PT1874766E (OSRAM)
SI (1) SI1874766T1 (OSRAM)
TW (1) TWI377206B (OSRAM)
WO (1) WO2006108127A2 (OSRAM)
ZA (1) ZA200708071B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063671B2 (en) * 2002-06-21 2006-06-20 Boston Scientific Scimed, Inc. Electronically activated capture device
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
ATE441646T1 (de) * 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
ATE431824T1 (de) 2004-11-05 2009-06-15 Theravance Inc Chinolinon-carboxamid-verbindungen
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound
CN102775396B (zh) 2005-11-08 2014-10-08 沃泰克斯药物股份有限公司 Atp-结合弹夹转运蛋白的杂环调控剂
US20080287486A1 (en) * 2007-05-17 2008-11-20 Theravance, Inc. Prokinetic agent for bowel preparation
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
NZ614151A (en) * 2007-12-07 2015-04-24 Vertex Pharma Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
HUE038141T2 (hu) * 2009-04-13 2018-10-29 Theravance Biopharma R&D Ip Llc 5-HT4 receptor agonisták és acetilkolinészteráz inhibitorok kombinációi kognitív rendellenességek kezelésére
EP2531510B1 (en) 2010-02-01 2014-07-23 Novartis AG Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
ES2527849T3 (es) 2010-02-02 2015-01-30 Novartis Ag Derivados de ciclohexilamida como antagonistas del receptor de CRF
ES3017582T3 (en) 2010-04-07 2025-05-13 Vertex Pharma Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
CN105848657B (zh) 2013-11-12 2020-05-22 沃泰克斯药物股份有限公司 制备用于治疗cftr介导的疾病的药物组合物的方法
SI3661518T1 (sl) * 2017-07-31 2025-01-31 Alfasigma S.P.A. Načini zdravljenja simptomov gastropareze z zdravilom velusetrag
US10570127B1 (en) 2018-11-05 2020-02-25 Renexxion, Llc Material and methods for the treatment of gastro-intestinal disorders
JP2025533507A (ja) 2022-09-20 2025-10-07 アルファシグマ ソシエタ ペル アチオニ 慢性偽性腸閉塞症（ｃｉｐｏ）の治療に使用するためのベルセトラグ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3122671B2 (ja) 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
CA2097815C (en) 1990-12-28 2001-04-17 Fumio Suzuki Quinoline derivative
EP0670319A4 (en) 1992-11-20 1996-01-17 Thaisho Pharmaceutical Co Ltd HETEROCYCLIC COMPOUNDS.
JP3829879B2 (ja) 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
US7105195B2 (en) * 2003-07-25 2006-09-12 General Mills, Inc. Reduced trans fat product
WO2005049608A1 (en) 2003-11-24 2005-06-02 Pfizer Japan, Inc. Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
ATE441646T1 (de) 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
ATE431824T1 (de) 2004-11-05 2009-06-15 Theravance Inc Chinolinon-carboxamid-verbindungen
JP2008530225A (ja) 2005-02-17 2008-08-07 セラヴァンス， インコーポレーテッド インダゾール−カルボキサミド化合物の結晶型
WO2006094063A1 (en) 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound

Also Published As

Publication number Publication date
NO20075574L (no) 2007-11-02
KR101322873B1 (ko) 2013-10-30
HRP20100629T1 (hr) 2010-12-31
PT1874766E (pt) 2010-11-30
JP5230407B2 (ja) 2013-07-10
BRPI0610657A2 (pt) 2010-07-13
CN101151264A (zh) 2008-03-26
EA200702161A1 (ru) 2008-04-28
EP1874766A2 (en) 2008-01-09
IL186023A (en) 2011-09-27
PL1874766T3 (pl) 2011-02-28
EA012115B1 (ru) 2009-08-28
MA29403B1 (fr) 2008-04-01
EP1874766B1 (en) 2010-09-01
AR110019A2 (es) 2019-02-13
JP2012153725A (ja) 2012-08-16
IL186023A0 (en) 2008-01-20
TW200643020A (en) 2006-12-16
CA2603654A1 (en) 2006-10-12
ATE479682T1 (de) 2010-09-15
AU2006232129A1 (en) 2006-10-12
WO2006108127A3 (en) 2007-01-04
DE602006016586D1 (de) 2010-10-14
PE20061310A1 (es) 2007-01-23
US7728004B2 (en) 2010-06-01
US20160095849A1 (en) 2016-04-07
HK1110866A1 (en) 2008-07-25
US20100197728A1 (en) 2010-08-05
CA2603654C (en) 2014-05-27
US20140256769A1 (en) 2014-09-11
US9126994B2 (en) 2015-09-08
NZ561900A (en) 2010-12-24
NO339699B1 (no) 2017-01-23
US8658671B2 (en) 2014-02-25
US9402840B2 (en) 2016-08-02
AR053208A1 (es) 2007-04-25
WO2006108127A2 (en) 2006-10-12
TWI377206B (en) 2012-11-21
CN101151264B (zh) 2011-07-06
AU2006232129B2 (en) 2012-07-12
US20060229332A1 (en) 2006-10-12
CY1111275T1 (el) 2015-08-05
KR20070116988A (ko) 2007-12-11
DK1874766T3 (da) 2010-12-06
JP2008535848A (ja) 2008-09-04
SI1874766T1 (sl) 2010-12-31
ES2350495T3 (es) 2011-01-24
MY151075A (en) 2014-03-31
MX2007012438A (es) 2007-12-05

Similar Documents

Publication Publication Date Title
ZA200708071B (en) Crystalline form of a quinolinone-carboxamide compound
IL185471A0 (en) Crystalline forms of a biphenyl compound
IL180853A0 (en) Crystalline form of a biphenyl compound
PL2155200T3 (pl) Postać krystaliczna pochodnej karbamoilo-cykloheksanu
IL197825A0 (en) Crystalline forms of a thizolidinedione compound and manufacturing methods thereof
IL190880A0 (en) Preparation of a crystalline antibiotic substance
IL196722A0 (en) Crystalline antifungal compounds
IL183380A0 (en) Crystalline forms of linezolid intermediate
GB0504995D0 (en) Use of a compound
ZA200903614B (en) New crystalline forms
IL184945A0 (en) Crystalline forms of pregabalin
GB0602778D0 (en) Novel compound
IL177762A0 (en) Bimatoprost crystalline form i
AP2007004282A0 (en) Derivatives of A 1-phenyltriazole as antiparasiticagents
IL187981A0 (en) Crystalline forms of a pyrrolotriazine compound
GB0512429D0 (en) Novel compound
ZA200806859B (en) Novel crystalline compounds
ZA201104319B (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
EP1951257A4 (en) CRYSTALLINE FORMS
GB0506967D0 (en) Novel crystalline salt
EP1983997A4 (en) CRYSTALLINE FORMS OF A FARNESYL DIBENZODIAZEPINONE
GB0514685D0 (en) A ntineoplastic compounds
ZA200706428B (en) Crystalline ACAT inhibitor
GB0522829D0 (en) Use of a compound
IL177451A0 (en) Crystalline forms of a pharmaceutical compound